CClinicalTrials.gg
RecruitingNCT05571579GLIOLIUpdated Jan 20, 2026

Biological Collection of Brain Tumors

An observational study in Brain Tumor, sponsored by Hospices Civils de Lyon. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-20.

Sponsored by Hospices Civils de Lyon · Observational

From the registry’s dates

  • Started Nov 2023; still recruiting 2 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Study summary

The objective of this study is to build a collection of biological samples from patients with brain tumors.

02

Conditions studied

  • Brain Tumor

Browse trials for

Keywords

  • Brain tumor
03

In context

Brain Neoplasms

1,960 studies on the registry are indexed under Brain Neoplasms; 516 are open to participants now.

This study's planned enrollment of 500 is above the median of 100 across 380 observational studies indexed under Brain Neoplasms.

Browse Brain Neoplasms studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patient with brain tumor

Inclusion criteria

  • Patient whose diagnosis of brain tumor has been confirmed.
  • Adult patients, from 18 years old and without upper age limit
  • Patient affiliated to a social security scheme or equivalent.
  • Patient able to consent, having dated and signed an informed consent

Exclusion criteria

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • Patient under guardianship or curators.
  • Persons deprived of their liberty by a judicial or administrative decision
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • brain tumors

    Biological: blood and/or csf collection

Interventions

  • Biologicalblood and/or csf collection

    blood and/or collection Only once : * 1 tube of blood of 4 mL on dry tube with or without gel, * 2 tubes of blood of 4 mL on EDTA tube, If CSF collected for diagnosis is available, it can be sent for storage in the collection.

06

What researchers measure

Primary outcomes

  1. number of biological samples

    number of biological samples

    Time frame: 10 years

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05571579
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Oct 7, 2022
Start date
Nov 22, 2023
Primary completion
Nov 22, 2033 (estimated)
Completion
Nov 22, 2033 (estimated)
Last update
Jan 20, 2026

Study contacts

François DUCRAY, Pr
Contact
francois.ducray@chu-lyon.fr
04 72 68 13 21 ext. +33
Apolline Barthelmé
Contact
Apolline.barthelme@chu-lyon.fr
04 26 73 97 87 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion